The Discounted Cash Flow (DCF) valuation of Integra Lifesciences Holdings Corp (IART) is 15.91 USD. With the latest stock price at 13.49 USD, the upside of Integra Lifesciences Holdings Corp based on DCF is 17.9%.
Based on the latest price of 13.49 USD and our DCF valuation, Integra Lifesciences Holdings Corp (IART) is a buy. buying IART stocks now will result in a potential gain of 17.9%.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 9.1% | 7.5% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 2.98 - 63.76 | 15.91 |
| Upside | -77.9% - 372.7% | 17.9% |